Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Lupin Q4 Fails To Cheer But Signals Stabilization Of US Generic Market

Thu, 05/16/2019 - 8:23pm

Lupin’s management refer to multiple indicators suggesting the US generics segment is stabilizing. But traction for some key launches, delivering...

      Related Stories 

Vonoprazan Provides Foundation For Newly Minted Phathom

Thu, 05/16/2019 - 5:53pm

Newly formed US venture Phathom, with industry veteran Tachi Yamada on board, has picked up selected rights to P-CAB molecule...

      Related Stories 

Where Is J&J Investing For The Future? Cell Therapy, Gene Therapy And RNA

Thu, 05/16/2019 - 1:26pm

Janssen global head of R&D Mathai Mammen said the three areas are therapeutic modalities J&J is prioritizing for future drug...

      Related Stories 

Pediatric Oncology Advances Could Prompt More FDA-Required Studies

Thu, 05/16/2019 - 11:22am

Findings being presented at ASCO next month could signify major increase in targets relevant to pediatric oncology, meaning sponsors should...

      Related Stories 

Bluebird Lays Some New Eggs, But They'll Take Time To Hatch

Thu, 05/16/2019 - 10:48am

Management outlined four new oncology and one rare disease program during an analyst day. CEO Nick Leschly also talked to...

      Related Stories 

What Late-Breakers To Look Out For At ASCO 2019

Thu, 05/16/2019 - 10:38am

Delegates at this year’s ASCO meeting in Chicago will hear late-breaking clinical data for a number of studies from AstraZeneca...

      Related Stories 

Vertex Targeting Protein Degradation In $1bn Kymera Deal

Thu, 05/16/2019 - 6:51am

Vertex and Kymera will use insights into the ubiquitin-proteasome pathway, for sending unwanted proteins off to recycling, to discover new...

      Related Stories 

BI Bags Third Place For Humira Biosimilar in US With AbbVie Pact

Thu, 05/16/2019 - 6:30am

Boehringer Ingelheim has settled litigation with AbbVie over Humira by striking a deal that allows it to launch its biosimilar...

      Related Stories 

UK's ICR Targets Cancer Resistance To Drugs

Thu, 05/16/2019 - 5:33am

The institute is putting £75m into a new facility where it hopes to develop therapies that aim to directly confront...

      Related Stories 

F-star CEO: Revamped Merck KGaA Pact Is First Step In New Corp Direction

Thu, 05/16/2019 - 12:59am

F-star CEO tells Scrip reconfiguring biotech’s pact with Merck KGaA on oncology asset FS118 is UK group’s first big move...

      Related Stories 

How To Deliver Your China Growth Story: Trends To Watch

Wed, 05/15/2019 - 5:16pm

Caught between a grueling centralized bidding process and now potentially in trade war crossfire, foreign pharma firms have a lot...

      Related Stories 

ImmunoGen Needs Another Phase III For Its ADC In Ovarian Cancer

Wed, 05/15/2019 - 2:09pm

The biotech’s hopes for an accelerated approval on subgroup data were dashed by the US FDA, but it will work...

      Related Stories 

J&J Plans 10 Potential Blockbuster Filings By 2023

Wed, 05/15/2019 - 12:02pm

The company outlined pharma growth drivers, including 14 currently marketed medicines that will achieve $1bn or more in sales by...

      Related Stories 

Stallergenes Greer's Delisting To Focus Leadership On Facility Issues

Wed, 05/15/2019 - 8:51am

The acquisition of the UK-headquartered leading allergy immunotherapy firm by its private majority shareholder is expected to remove the distraction...

      Related Stories 

Solid Biosciences’ DMD Gene Therapy Undermined By Safety Wobbles

Wed, 05/15/2019 - 7:53am

Another setback for the novel therapy leaves rivals Sarepta and Pfizer in a stronger position in a potentially highly rewarding...

      Related Stories 

Court Restrains Dr Reddy’s In Indian Belviq Case

Wed, 05/15/2019 - 7:14am

An Indian court has granted an interim injunction against Dr Reddy’s in a case concerning the alleged infringement of Eisai’s...

      Related Stories 

Joy For SMA Patients As NICE And Biogen Break Spinraza Deadlock

Wed, 05/15/2019 - 6:40am

Between 600-1,200 people in England and Wales may be able to get Spinraza now that after 17 months of negotiations...

      Related Stories 

Pages